Amgen's research and development facility in San Francisco. (courtesy photo) Seven months after Amgen approached the city of Thousand Oaks to discuss the approval process for a planned $600 million science and innovation center, the biotech giant held an Oct. 30 ceremonial groundbreaking for the proposed structure. Announced in September, the planned center at the…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
